Close Menu

NEW YORK (GenomeWeb) – Abbott said Wednesday that its fourth quarter diagnostic revenues grew 52 percent year over year on a reported basis and 7 percent year over year on a comparable operational basis to $1.91 billion from $1.26 billion in the year-ago period.

For the three months ended Dec. 31, 2017, Abbott reported worldwide revenues of $7.59 billion, up 42 percent from $5.33 billion a year ago, and topping the average Wall Street estimate of $7.39 billion. Sales increased 8 percent on a comparable operational basis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.